Achaogen, Inc. (NASDAQ:AKAO) reached 847.21% versus a 1-year low price of $2.69. The stock was last seen 5.03% higher, reaching at $25.48 on Thursday, May 18, 2017. At recent session, the prices were hovering between $24.17 and $25.95. This company shares are 14.36% off its target price of $29.14 and the current market capitalization stands at $895.37M. The recent change has given its price a 9.08% lead over SMA 50 and -8.31% deficit over its 52-week high. The stock witnessed 14.93% gains, 15.82% gains and 377.15% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AKAO’s volatility during a week at 8.17% and during a month it has been found around 6.87%.

Achaogen, Inc. (AKAO) Top Holders

Institutional investors currently hold around $720 million or 88.3% in AKAO stock. Look at its top three institutional owners. Nea Management Company, Llc owns $126.52 million in Achaogen, Inc., which represents roughly 14.13% of the company’s market cap and approximately 17.57% of the institutional ownership. Similar statistics are true for the second largest owner, Fmr Llc, which owns 4,778,253 shares of the stock are valued at $115.92 million. The third largest holder is Baker Bros. Advisors Lp, which currently holds $111.17 million worth of this stock and that ownership represents nearly 12.42% of its market capitalization.

Achaogen, Inc. 13F Filings

At the end of 03/31/2017 reporting period, 58 institutional holders increased their position in Achaogen, Inc. (NASDAQ:AKAO) by some 7,949,286 shares, 42 decreased positions by 4,460,999 and 7 held positions by 17,254,976. That puts total institutional holdings at 29,665,261 shares, according to SEC filings. The stock grabbed 32 new institutional investments totaling 3,492,293 shares while 16 institutional investors sold out their entire positions totaling 1,149,155 shares.

Achaogen, Inc. (NASDAQ:AKAO) Insider Trades

Multiple company employees have indulged in significant insider trading. Achaogen, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CEO Hillan Kenneth J. has sold 3,079 shares of Achaogen, Inc. (AKAO) in trading session dated Mar. 14, 2017. These shares are worth $81,840 and were traded at $26.58 each. The SEC filing shows that Friedland Ian performed a sale of 1,026 shares. The SVP, Chief Medical Officer disposed these shares by way of transaction on Feb. 21, 2017. The company’s shares were given away at $22.76 per share worth to an income of some $23,352 on account of Friedland Ian.

See Remarks, Sarpangal Zeryn, sold 439 common shares of Achaogen, Inc. (AKAO) in the open market. In a transaction dated Feb. 21, 2017, the shares were put up for sale at an average price of $22.76, raking in a sum of $9,992. After this sale, 16,522 common shares of AKAO are directly owned by the insider, with total stake valued at $420,981.

In the transaction dated Feb. 21, 2017, the great number of shares disposed came courtesy the CEO; Hillan Kenneth J. disposed a total of 1,696 shares at an average price of $22.76, amounting to approximately $38,601. The insider now directly owns 61,501 shares worth $1,567,045.

Achaogen, Inc. (AKAO) Analyst Guide

Several analysts have released their opinion on Achaogen, Inc. (NASDAQ:AKAO), with 9 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.1 average brokerage recommendation.

Previous articleFortress Biotech, Inc. (NASDAQ:FBIO) held by 13 SEC 13F Filers
Next article44 hedge funds sold their entire positions in TerraVia Holdings, Inc. (NASDAQ:TVIA)